Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Jun 30, 2026 P1I2: 7 added · 10 removed · 54 modified
P2I1A: no material changes, the filing says
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 19, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K May 29, 2026 7.01 Regulation FD disclosure
8-K May 20, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K May 11, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K/A Oct 9, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 28, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Apr 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 2, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 25, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 10, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Dec 31, 2025
8-K Feb 9, 2026 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 9, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 30, 2026 3.02 Unregistered sales of equity securities; 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Feb 5, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 27, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Dec 30, 2025 5.04 Suspension of trading under employee benefit plans
8-K/A Nov 17, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Sep 30, 2025 1: 7 added · 12 removed · 33 modified
1A: 18 added · 13 removed · 57 modified
7: 36 added · 38 removed · 85 modified
8-K Nov 17, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 9, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 16, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Sep 30, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.